Leo Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Leo Wealth, LLC
- $1.12 Trillion
- Q4 2024
A detailed history of Leo Wealth, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Leo Wealth, LLC holds 635 shares of REGN stock, worth $427,342. This represents 0.04% of its overall portfolio holdings.
Number of Shares
635
Previous 1,011
37.19%
Holding current value
$427,342
Previous $1.06 Billion
57.45%
% of portfolio
0.04%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,500Shares Held
83MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.27 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.68 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.04 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.3 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.89 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...